Fundamental Analysis
57 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +2.9% | +53.7% | 2 / 3 | +20.7% | +1.34 pp | -0.27 pp | +8.0% | 1.46 | 9.22 | 568 | +20,7% | 8,9 | +2,9% | 9.22 | 24.56 | −62,5% |
| Pts | 0 | 12 | 8 | 12 | 8 | 4 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 9.000 (close price on 2026-10-19)EPS (TTM): 976,6
Financial charts
1.Revenue & growth
VND bn568Q2/26
1.Revenue & growth
VND bn568Q2/26
2.Profit & growth
VND bn8,93Q2/26
3.Profit mix (Penman)
VND bn34,2Q2/26
4.Margins & cost structure
%9.2%Q2/26
5.Returns & cash cycle
% · days7.3%Q2/26
6.Earnings quality & cash
VND bn-54,2Q2/26
7.Asset structure
VND bn1.493Q2/26
8.Funding & debt health
VND bn · times1.493Q2/26
9.Revenue backlog
VND bn263Q2/26
10.Valuation
times · %9,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %372Q2/26
Adjusted EPS growth, latest quarter
2.9%
Average adjusted EPS growth, 3 quarters
53.7%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26